United Therapeutics (UTHR) Intangibles (2011 - 2020)

United Therapeutics (UTHR) has 10 years of Intangibles data on file, last reported at $1.4 million in Q1 2020.

• For the quarter ending Q1 2020, Intangibles fell 12.5% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2020 stood at $1.4 million (down 12.5% YoY), and the FY2019 full-year result was $128.9 million, up 7956.25% from the prior year.
• Intangibles declined to $1.4 million in Q1 2020, from $128.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $128.9 million in Q2 2019 to a low of $500000.0 in Q2 2016.
• A 5-year average of $27.4 million and a median of $1.7 million in 2016 frame the typical range for Intangibles.
• Across the five-year window, Intangibles plunged 96.77% in 2016 and surged 7956.25% in 2019, its largest moves.
• Tracing UTHR's Intangibles over 5 years: stood at $1.7 million in 2016, then soared by 282.35% to $6.5 million in 2017, then plunged by 75.38% to $1.6 million in 2018, then surged by 7956.25% to $128.9 million in 2019, then slumped by 98.91% to $1.4 million in 2020.
• Business Quant data shows UTHR's Intangibles at $1.4 million in Q1 2020, $128.9 million in Q4 2019, and $128.9 million in Q3 2019.